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Abstract
Background: Hundreds of thousands of human embryos are cultured yearly at in vitro fertilization (IVF) centers worldwide,
yet the vast majority fail to develop in culture or following transfer to the uterus. However, human embryo phenotypes have
not been formally defined, and current criteria for embryo transfer largely focus on characteristics of individual embryos. We
hypothesized that embryo cohort-specific variables describing sibling embryos as a group may predict developmental
competence as measured by IVF cycle outcomes and serve to define human embryo phenotypes.
Methodology/Principal Findings: We retrieved data for all 1117 IVF cycles performed in 2005 at Stanford University Medical
Center, and further analyzed clinical data from the 665 fresh IVF, non-donor cycles and their associated 4144 embryos. Thirty
variables representing patient characteristics, clinical diagnoses, treatment protocol, and embryo parameters were analyzed
in an unbiased manner by regression tree models, based on dichotomous pregnancy outcomes defined by positive serum
ß-human chorionic gonadotropin (ß-hCG). IVF cycle outcomes were most accurately predicted at ,70% by four non-
redundant, embryo cohort-specific variables that, remarkably, were more informative than any measures of individual,
transferred embryos: Total number of embryos, number of 8-cell embryos, rate (percentage) of cleavage arrest in the cohort
and day 3 follicle stimulating hormone (FSH) level. While three of these variables captured the effects of other significant
variables, only the rate of cleavage arrest was independent of any known variables.
Conclusions/Significance: Our findings support defining human embryo phenotypes by non-redundant, prognostic
variables that are specific to sibling embryos in a cohort.
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Introduction
Developmental arrest of human embryos cultured in vitro is
common and presents a major obstacle to achieving pregnancy
through IVF, as well as a major obstacle to research in human
embryonic stem cell (hESC) biology [1,2,3,4,5,6,7]. While the
culture of embryos to blastocyst stage for subsequent transfer yields
high pregnancy rates and minimizes the risk of multiple gestation,
the availability of blastocysts is limited even in the best IVF clinics
because of the high rates of attrition in in vitro embryo culture
[1,3,4,8,9,10,11].
Although developmental defects such as cleavage arrest,
polyploidy, and fragmentation are commonly encountered and
have been used for scoring individual embryos in IVF
[11,12,13,14,15,16,17,18,19,20,21], the lack of well-defined hu-
man embryo phenotypes has hindered translational research and
mechanistic investigations. One key challenge to defining human
embryo phenotypes relates to the unclear and often highly
interactive relationships amongst variables pertaining to patient
characteristics, clinical infertility diagnoses, IVF treatment proto-
cols, and observed embryo characteristics. Further, since any
single couple may typically produce a few oocytes or embryos that
are abnormal merely by chance, it is difficult to determine whether
sibling embryos as a group, or an embryo cohort, is ‘‘normal’’.
(Note that ‘‘embryo cohort’’ refers to an embryo sibling group
from the same couple within the same IVF treatment.)
Nonetheless, we envision that the identification of cohort-specific
parameters to define human embryo phenotypes is a necessary
step towards translational investigations of molecular determinants
of developmental competence. Thus, we sought to test the
hypothesis that embryo cohort-specific variables have prognostic
value in measuring IVF cycle outcomes by identifying non-
redundant, prognostic variables in an unbiased manner using
regression tree models.
PLoS ONE | www.plosone.org 1 July 2008 | Volume 3 | Issue 7 | e2562Results
Of all 1117 IVF treatments performed at Stanford University in
2005, 822 were fresh IVF cycles that used the patients’ own
oocytes (Figure 1A). Based on our exclusion criteria, 157 cycles
were excluded for a variety of medical and non-medical reasons
(see results in Supporting Information Text S1 for details). Clinical and
embryology data on the remaining 665 cycles that satisfied
inclusion and exclusion criteria, and their 4144 embryos,
respectively, were analyzed to test the hypothesis that cohort-
specific variables predict IVF cycle outcomes (Figure 1). Of those
4144 embryos, the number of blastomeres or cells on day 3 was
recorded for 4002 embryos (96.6%). Overall, 38.8% had 8 cells,
the developmentally appropriate cell number, while 18.2% of
embryos had #4 cells, and 33.6% had 5–7 cells (Figure 2).
Prognostic Significance and Correlation of Variables
We systematically examined the association of each variable
with IVF outcomes, and the correlation of each pair of variables.
Pair-wise logistic regression tests confirmed many known prog-
nostic variables, including female age, day 3 FSH, and the number
of 8-cell embryos. However, in addition to these known prognostic
variables, we observed that cohort-specific variables such as
fertilization rate and the rate of cleavage arrest were also
significantly associated with IVF cycle outcome (p,0.001;
Table 1). In contrast, except for male factor infertility (p,0.05),
none of the conventional clinical infertility diagnoses were
significantly associated with IVF outcomes. Notably, despite a
high degree of correlation between many variables and age or day
3 FSH level, which estimates ovarian aging, neither age nor day 3
FSH level was correlated to cohort-specific embryo parameters
(see Table S1). Collectively, these results suggest that determinants
other than age-related mechanisms and clinical diagnoses impact
cohort-specific embryo developmental competence.
Thresholds of Non-redundant, Prognostic Variables
Defining Human Embryo Cohort Phenotypes
Sequential Multiple Additive Regression Tree (MARTH) and
Classification and Regression Tree (CART) analyses of all 30
variables (listed in Table 1 and its legend) determined that IVF
cycle outcomes were most accurately predicted at ,70% by using
only four non-redundant variables: total number of embryos, rate
of cleavage arrest in an embryo cohort, the number of 8-cell
embryos in a cohort, and day 3 FSH level. Remarkably, these four
variables all describe the embryo cohort rather than individual
embryos, and were more informative than age, clinical diagnoses,
or any measures of the transferred embryos. Interestingly, the total
number of embryos, day 3 FSH, and the number of 8-cell embryos
depended on and thus captured the effects of many other
variables. In contrast, the rate of cleavage arrest was independent
of any of those known variables. (Details on MARTH and CART
analyses are reported in Text S1, and Figure S1)
Of the prognostic thresholds identified, the most robust
phenotypes are A1 and A2, and B1 and B2 (Table 2). Number
of embryos ,6o r$6 is used by all 5 top CART models, defines
all other phenotypes (B to F), and can be applied to all cases.
Specifically, the phenotype defined by having fewer than 6
embryos, has an odds ratio of 3.9 for no pregnancy compared to
cases with $6 embryos (95% Confidence Interval [CI], 2.8 to 5.5).
Similarly, the next most robust phenotypes are defined by the
number of embryos and cleavage arrest rate, such that for cases
with $6 embryos, those with cleavage arrest rate .14.6% are 3.0
times more likely to result in no pregnancy than those with
cleavage arrest rate #14.6% (95% CI, 1.9 to 4.9).
Figure 1. Source of data. A) IVF cycles performed in 2005. B)
Utilization of oocytes and embryos in 665 fresh, non-donor IVF cycles.
* All numbers in Panel A indicate the number of cycles and numbers in
Panel B indicate the number of oocytes or embryos. Fresh cycles are
defined by ovarian stimulation of gonadotropins and embryo transfer
performed within the same cycle; cryopreserved cycles utilize embryos
that were obtained and cryopreserved from a previous cycle; ‘‘freeze-
all’’ are cycles in which ovarian stimulation was performed, but embryos
were cryopreserved instead of being transferred back within the same
cycle for medical or non-medical reasons. 157 cycles were removed
from analysis for a variety of medical and non-medical reasons that did
not result in fresh embryo transfer (see SI Text for details).
doi:10.1371/journal.pone.0002562.g001
Human Embryo Phenotypes
PLoS ONE | www.plosone.org 2 July 2008 | Volume 3 | Issue 7 | e2562In contrast, the rest of the thresholds listed in Table 2 are used
by only 1 CART model each, and is applicable to fewer cases.
However, as some of those phenotypes describe very specific
subset of cases and have odds ratios that are highly discriminatory,
they may be extremely useful depending on the clinical or
translational research context. For example, for cases with $6
embryos, having cleavage arrest rates of 14.6–52.8% and .52.8%
increase the odds of no pregnancy by 2.6 (95% CI 1.6 to 4.3) and
10.6 (95% CI 3.2 to 49.6), respectively, when compared to cases
with cleavage rates of #14.6%.
Discussion
Since the introduction of IVF in the 1970s, the major challenges
of assisted reproductive technologies (ART) have been the high
attrition rates of embryos cultured in vitro [1,3,4,8,9,10,11,22,23],
the limited value of embryo morphology in predicting develop-
mental competence [24,25,26], and finding criteria to help
determine the number of embryos to transfer [22,23]. In addition,
the benefit of aneuploidy screening by preimplantation genetic
screening (PGS) has recently been refuted [27]. Thus, there is a
need to reassess factors that determine human embryo quality.
Our findings represent a first step towards this goal by using
regression tree models, MARTH and CART, as unbiased methods
to analyze IVF and embryo data. These methods allowed us to
consider and control for a large number of variables, even if only a
few of them have significant impact on outcomes. This feature is
critical for the analysis of the highly interactive and multicollinear
IVF and human embryo data, as arbitrary selection of variables may
compromise completeness of data and introduce bias, while
including all of them would cause the conventional multivariate
regression to breakdown (see SI Text). Indeed, such application of
CART analysis was taken by Guzick et al. to define semen
parameters that predicted male infertility [28]. In our study, we
further used MARTH, a more powerful statistical method that
‘‘boosts’’ or increases accuracy in the CART method [29,30,31,32].
We identified four non-redundant variables that predict
outcomes in the current IVF cycle with ,70% accuracy. Most
remarkably, these variables–total number of embryos, cleavage
arrest rate, number of 8-cell embryos, and day 3 FSH (in order of
relative importance)–describe the entire embryo cohort, and are
more predictive than any measures of the transferred embryos. In
addition, we show that most prognostic information carried by
highly interacting and multicollinear conventional variables such
as age and clinical diagnoses, is captured by three of the four
variables.
Previous reports mainly focused on the prognostic value of
individual embryo scores, in which the relative weighting of score
components was determined arbitrarily rather than by objective or
statistical methods [15,18]. Further, although individual variables
that were significantly related to IVF cycle outcomes were
reported, there has been no attempt to compare their relative
Figure 2. Distribution of all embryos from 665 fresh, non-
donor IVF cases according to their cell number on Day 3.
doi:10.1371/journal.pone.0002562.g002
Table 1. Association of each variable with pregnancy
outcome.
Variables Estimate* S.E. P-Value
Patient Characteristics and Clinical
Diagnoses
{
Age 20.10 0.02 2.16E-007
Maximum Day 3 FSH level 20.08 0.03 1.70E-003
Gravidity 0.036 0.066 5.86E-001
Male Factor (infertility diagnosis) 0.50 0.24 3.71E-002
IVF Cycle Characteristics
Microdose lupron (flare) protocol 21.14 0.24 2.53E-006
Antagonist protocol 20.74 0.19 9.98E-005
Performance of ICSI 20.15 0.16 3.47E-001
No. of oocytes 0.08 0.01 1.58E-009
Embryo Cohort Parameters
Fertilization rate 1.24 0.36 5.37E-004
No. of embryos 0.14 0.02 2.67E-012
Average cell no. of embryos 0.29 0.06 6.34E-006
No. of 8-cell embryos 0.26 0.04 2.88E-012
Percentage of 8-cell embryos 0.76 0.28 5.75E-003
Cleavage arrest rate
{ 21.28 0.35 2.76E-004
Average grade of embryos 20.091 0.17 5.88E-001
Parameters of Transferred Embryos
Day 5 embryo transfer
1 1.40 0.19 7.51E-013
No. of embryos transferred 0.0058 0.053 9.12E-001
Average cell no. of embryos transferred 0.47 0.07 2.19E-010
Percentage of transferred embryos at the
8-cell stage
1.33 0.21 5.35E-010
No. of 8-cell embryos transferred 0.41 0.08 4.40E-008
No. of embryos with #4 cells transferred 22.14 0.49 1.06E-005
Average grade of embryos transferred 20.52 0.17 2.61E-003
*Positive and negative estimates indicate association with positive and negative
pregnancy outcomes, respectively.
{Clinical infertility diagnoses that were not significantly associated with
pregnancy outcome (p-value .0.05) were not listed: uterine factor, polycystic
ovarian syndrome, endometriosis, tubal ligation, tubal disease, hydrosalpinges,
unexplained infertility, and ‘‘other diagnoses’’. Each IVF case may have more
than one clinical infertility diagnosis.
{Cleavage arrest rate is defined as the percentage of embryos with 4 or fewer
cells on Day 3 of in vitro culture.
1Day 5 embryo transfer is arbitrarily listed under Parameters of Transferred
Embryos. It can also be considered an Embryo Cohort Parameter, as it depends
on the total number of embryos and the number of 8-cell embryos.
doi:10.1371/journal.pone.0002562.t001
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[12,14,17,21]. For example, age, serum FSH, number of oocytes
and number of embryos were each reported to be significantly
related to IVF outcomes [17]. However, as shown by our analyses,
the prognostic value of age and number of oocytes was captured
by three of the four non-redundant variables. Similarly, the total
number of embryos and the number of 8-cell embryos have been
advocated for use in selecting patients for blastocyst transfer in
some IVF clinics to minimize the risk of having no embryos to
transfer due to failed blastocyst development [21,33,34]. However,
the prognostic value of these two variables has not been compared
to that of others, and their ability to capture prognostic
information from most other variables were not known.
Indeed, cleavage arrest rate is the only variable that is
independent of the others, which suggests that it may be linked
to biological mechanisms that are not currently recognized in the
management of clinical infertility or hESC biology. Encountered
in ,18% of human embryos cultured in vitro overall, its underlying
defects are likely diverse, and may be due to suboptimal in vitro
culture environment, biological mechanisms underlying infertility,
a generally poor reproductive fitness of our species or all of these
factors. Although cleavage arrest coincides with the maternal-
embryonic transition during which maternal transcripts are
degraded and the embryonic genome is activated [35], gene
expression analyses of arrested single human embryos did not
show failure in embryonic genome activation, and no specific
molecular defects have been identified [8,11].
Our study has some limitations. Although we took advantage of
the power of regression tree models to analyze a very
comprehensive range of variables, we did not include cryopres-
ervation of sibling embryos and assisted hatching as variables. In
addition, it would also be valuable to analyze blastocyst
development rate of sibling embryos, because this variable has
been shown to correlate with positive pregnancy outcomes [36].
Those variables are now being investigated in a larger study that
encompasses four years of data. As the goal of this current study
was to explore new paradigms in human embryo development in
IVF, and not to arrive at recommendations to change clinical
practice, we used positive serum hCG status as the surrogate
outcome measure to identify nonredundant predictors of IVF
cycles in which at least one embryo attaches to the endometrium
and secretes hCG, from those in which no embryo attaches. In the
future, we will use later endpoints, such as clinical pregnancy or
live birth, to address clinical questions.
In spite of over 30 years of ART, many challenges remain.
Ongoing and future investigations may incorporate approaches
common to genetics and developmental biology, in order to
reassess defective human embryo development in terms of
phenotypes that can be diagnosed, defined, and translated into
improved clinical practices. Collectively, our results indicate that
embryos from a cohort share as yet undefined genetic or
epigenetic determinants of developmental competence, which is
consistent with the greater increase in implantation relative to
pregnancy rates conferred by blastocyst transfer [37]. The concept
Table 2. Prognostic thresholds defining cohort-specific phenotypes.
Embryos
(No.)*
Cleavage
Arrest
(%)*
8-cell
embryo
(No.)*
FSH
(mIU/
mL)*
Pregnancy
-No. (%){
No
Pregnancy
-No. (%) {
Applicable
Cases–No.
(%) 1
No.
Trees "
Reference
ConditionI
Odds
Ratio
95%
Confidence
Interval (C.I.)
A1** $6 177 (57.7) 130 (42.3) 307 (46.2) 5
A2 ,6 92 (25.7) 266 (74.3) 358 (53.8) 5 A1 3.9 (2.8, 5.5)
B1 $6 #14.6 112 (70.4) 47 (29.6) 159 (23.9) 4
B2 $6 .14.6 65 (43.9) 83 (56.1) 148 (22.3) 4 B1 3.0 (1.9, 4.9)
B3 $6 14.6–52.8 62 (47.3) 69 (52.7) 131 (19.7) 1 B1 2.6 (1.6, 4.3)
B4 $6 #52.8 174 (60.0) 116 (40.0) 290 (43.6) n/a
B5 $6 .52.8 3 (17.6) 14 (82.3) 17 (2.6) 1 B1 10.6 (3.2, 49.6)
B4 6.7 (2.1, 30.9)
C1 $6 $2 157 (63.6) 90 (36.4) 247 (37.1) 1
C2 $6 ,2 20 (33.3) 40 (66.7) 60 (9.2) 1 C1 3.5 (1.9, 6.4)
D1 $6 .14.6 $2 51 (53.1) 45 (46.9) 96 (14.4) 1
D2 $6 .14.6 ,2 14 (26.9) 38 (73.1) 52 (7.8) 1 D1 3.0 (1.5, 6.5)
E1 $6 .14.6 $2 #4.6 14 (82.4) 3 (17.6) 17 (2.6) 1
E2 $6 .14.6 $2 .4.6 34 (46.9) 37 (53.1) 71 (12.2) 1 E1 4.8 (1.4, 23.4)
*Cohort phenotypes defined by thresholds of non-redundant prognostic variables. Each set of conditions (A–E) use ‘‘AND’’ as the operator where more than one
condition is listed.
{No. of cases that satisfy the threshold conditions and have pregnancy outcome. This percentage is calculated by using the No. Applicable Cases as denominator. In
general, conditions that discriminate between pregnancy and no pregnancy outcomes more highly are more robust and are expected to be more useful in both clinical
management and translational research.
{No. of cases that satisfy the threshold conditions and have no pregnancy outcome. This percentage is calculated by using the No. Applicable Cases as denominator.
1The No. Applicable Cases is the total number of cases that satisfy the threshold conditions. This percentage is calculated by using the total number of cycles (665) as
the denominator. In general, the larger the number of applicable cases, the more useful the set of conditions are for clinical management and counseling. However, for
the purpose of translational research, conditions that define a smaller number of cases may have more specific correlates on a molecular level.
"No. Trees shows the number of CART trees that utilize each set of conditions. There are a total of 5 trees. (See Supplemental Results.) Increased utilization indicates
‘‘usefulness’’ or ‘‘robustness’’ of that particular set of conditions.
IReference condition against which the Odds Ratio and 95% C.I. for having no pregnancy is calculated.
**Conditions A–E are listed from most robust and ‘‘useful’’ to least ‘‘useful’’ based on: the number of trees that utilize each set of conditions, the number of applicable
cases, and the odds ratio and 95% CI.
doi:10.1371/journal.pone.0002562.t002
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strictly focusing research efforts on selecting the ‘‘best’’ embryos to
identifying methods that would improve the quality of the entire
cohort. In addition, it raises the question of whether quality of the
entire cohort is intrinsic due to the shared origins of the embryos,
or if it is merely a result of group culture in vitro, especially since the
benefits of group culture have been reported in animal and human
embryos [38,39,40,41]. While embryo-specific parameters may
help to identify embryos that would maximize the immediate
pregnancy outcome for each couple, in the long term, under-
standing cohort-specific parameters is critical in counseling
patients, improving treatment, and ultimately in developing
mechanism-specific and more customized treatments.
We reason that well-defined criteria for embryo cohort
phenotypes in selecting abnormal embryos for molecular analyses
would maximize the chance of finding non-random genetic or
epigenetic molecular defects that are consistent in an embryo
cohort. For example, we are applying our findings to analyze
arrested embryos from embryo cohorts in which the number of
embryos are $6 and cleavage arrest rate is .52.8% (see
Condition B5 in Table 2). Overall, ,2.5% of fresh, non-donor
IVF cases (or ,17 cases per year, at our center) are expected to
fulfill these criteria. This approach should allow for objective
interpretation and comparison of data both internally and
amongst research groups.
We are also applying this research strategy to investigate
predictors of pregnancy outcomes in subsequent IVF cycles to
contrast couple- versus embryo cohort-specific prognostics variables.
More importantly, new hypotheses that are generated by this
investigation can befurthertested as additionalyears of data become
available. For example, our findings indicate that a low day 3 FSH
(,4.6 mIU/mL) confer high pregnancy rates in a very small and
specific subset of patients (see Condition E in Table 2), and offer new
perspectives on this controversial entity. While abnormally high
levels of day 3 FSH have been associated with ovarian aging, poor
ovarianresponseinIVF,andpoorIVFcycleoutcomes,manystudies
have cautioned against its use in clinical management due to its low
sensitivity, especially in women under 40 [42,43,44,45]. However,
the clinical utility of this test may be improved by determining
appropriate thresholds and conditions [46].
Similar to the implications for ART, our results also raise
questions about the effects of cohort-specific determinants on the
success rate of hESC line derivation, the quality of hESC lines, and
most importantly, embryo cohort selection for hESC line
derivation, or oocyte cohort selection for somatic cell nuclear
transfer. Currently, most scientific reports on successful derivation
of hESC lines do not include information on embryo cohort
characteristics, clinical information or IVF outcomes of sibling
embryos. Our findings suggest that correlation of clinical IVF data
and hESC line characteristics may provide valuable insight that
would move both the fields of reproductive medicine and hESC
research forward. We envision that dissection of human embryo
phenotypes and their corresponding molecular correlates is not
only a necessary step towards improving the treatment of clinical
infertility, but will also contribute significantly to research efforts in
the hESC field.
Materials and Methods
Data Collection, Inclusion and Exclusion Criteria
Data related to clinical diagnoses, IVF treatment protocol and
monitoring, embryology data and treatment outcomes for all IVF
cycles performed between January 1, 2005 and December 31,
2005 at Stanford University Medical Center were retrieved from
BabySentryPro (BabySentry Ltd, Limassol, Cyprus), a widely used
fertility database management system, or obtained from medical
and embryology records as necessary. Retrospective data collec-
tion, de-identification, and analysis were performed according to a
Stanford University Institutional Review Board-approved proto-
col. The inclusion criteria for data analysis were fresh, stimulated,
non-donor oocyte IVF cycles. We excluded cycles that did not
result in embryo transfer for any reason, cycles performed for
women aged over 45, and those performed for preimplantation
genetic screening.
Assessment of Embryo Development
Our standard clinical protocols for ART treatment, fertilization,
embryo culture, embryo assessment, cryopreservation criteria, and
clinical outcomes are described in methods in SI Text. The normal
progressionofhumanembryodevelopmentinvitroischaracterizedby
the appearance of 2 pronuclei at 16–20 hours after insemination as
evidence of fertilization on Day 1, with Day 0 as the day of oocyte
retrieval. By late Day 1, embryo development has reached the 2-cell
stage, followed by the 4-cell and 8-cell stages on Days 2 and 3,
respectively. On Days 4 and 5, embryo development is characterized
by the establishment of the morulaand blastocyststages,respectively.
All embryos were available for evaluation on Day 3. The day of
embryo transfer was determined by the number of blastomeres on
Day 3. In general,if4 or more8-cellembryos werepresent, we would
recommend extended embryo culture until Day 5, when blastocyst
transfer, which has been associated with higher pregnancy rates,
would be performed. If fewer than four 8-cell embryos were present,
embryo transfer would be performed on Day 3.
Patient, IVF Cycle, and Embryo Parameters
We analyzed 30 variables for association with IVF treatment
outcomes, as listed in Table 1, under four main categories: patient
characteristics and clinical diagnoses, IVF cycle characteristics,
embryo cohort parameters, and parameters of transferred
embryos. The cleavage arrest rate was defined as the percentage
of embryos within a cohort with 4 or fewer cells on Day 3 of in vitro
culture. All other variables were self-explanatory.
Statistical Analysis
Since some patients underwent more than one IVF cycle during
the study period, the analyses were performed based on treatment
cycles rather than patients. Statistical analyses were performed
based on the dichotomous outcomes of no pregnancy, as defined
by negative serum ß-hCG, and pregnancy, as defined by positive
serum ß-hCG, and included biochemical pregnancy, clinical
pregnancy, spontaneous abortion, and ectopic pregnancy. We
performed pair-wise logistic regression of each variable to the
outcome and determined the Pearson correlation coefficient
between each pair of continuous variables.
For the main analyses, boosted classification trees were
constructed by MARTH to identify non-redundant prognostic
variables, which were then further analyzed by CART to identify
thresholds that would define them as categorical variables.
MARTH is a robust method used to identify interactive structure
of variables that are predictive of outcomes [29,30,31,32]. The use
of cross-validation and boosting in parameter selection and model
assessment in MARTH also preserve parsimony and prevent over-
fitting [31]. In the MARTH tree constructions, the whole data set
is divided into 10 subsets to achieve 10 fold cross validation for
model assessment. The same 10 fold cross validation was repeated
1000 times to perform a robust prediction rate estimation and
identify tree models with the highest prediction rates in the CART.
While MARTH is powerful in selecting non-redundant prognostic
Human Embryo Phenotypes
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analysis results in simple algorithms, and more easily understood
‘‘decision trees’’, that are used in the medical literature [28]. Thus
non-redundant, prognostic variables identified by MARTH to
confer prediction were analyzed by CART to further define
prognostic thresholds.
Supporting Information
Text S1 This SI file contains details pertaining to methods,
results, and statistical analyses which may be of interest to certain
readers. It also contains an SI Table 2.
Found at: doi:10.1371/journal.pone.0002562.s001 (0.10 MB
DOC)
Table S1 Correlation between each pair of variables.
Found at: doi:10.1371/journal.pone.0002562.s002 (0.08 MB
DOC)
Figure S1 Variables and their relative importance in determin-
ing A) number of 8-cell embryos, B) day 3 FSH, and C) the total
number of embryos.
Found at: doi:10.1371/journal.pone.0002562.s003 (2.65 MB TIF)
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